Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine

The global health burden of infection‐associated cancers in the year 2002

2006 • 2,874 citations

British National Formulary

1958 • 2,539 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,644 citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

2004 • 1,099 citations

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

2011 • 654 citations

Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

2007 • 652 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

2011 • 472 citations

Health and Economic Implications of HPV Vaccination in the United States

2008 • 362 citations

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

2011 • 329 citations

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

2011 • 314 citations

Economic evaluation of human papillomavirus vaccination in the United Kingdom

2008 • 279 citations

The Information Centre

1961 • 244 citations

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

2006 • 200 citations

BRITISH NATIONAL FORMULARY 1981

1981 • 163 citations

Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

2011 • 124 citations

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

2009 • 118 citations

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model

2011 • 118 citations

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom

2009 • 106 citations

Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: A transmission dynamic model-based evaluation

2007 • 100 citations

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States

2009 • 97 citations

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK

2006 • 95 citations

Cervical screening programme, England: 1997–98

1999 • 69 citations

Stage-specific treatment costs for cervical cancer in the United Kingdom

1998 • 56 citations

Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses

2011 • 55 citations

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey

2009 • 51 citations

Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model

2008 • 37 citations

Age-Based Programs for Vaccination against HPV

2009 • 31 citations

Costs of running a universal adolescent hepatitis B vaccination programme

2005 • 29 citations

The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands

2011 • 28 citations